+91 88605 96059
Select Language
About
Education & Training
Conditions Treated
Awards & Achievement
Past Associations

Dr. Mohit Saxena (MD)

Rating : 4/5

Department : Oncology

Experience : 17+ years+ Years of Experience

Treats : Adults

About

Dr. Mohit Saxena is a highly skilled specialist with extensive experience in the field of Medical Oncology and Hematology. With over 7+ years of clinical experience and a total of 17+ years in the medical field, Dr. Mohit Saxena has established himself as a reputable healthcare professional. He possesses expertise in various treatment modalities, including Immunotherapy, Chemotherapy, Targeted Therapy, Precision Medicine, and Hormone Therapy. During his professional journey, Dr. Mohit Saxena worked as a consultant in Medical Oncology at Artemis Hospital for two and a half years. He gained vast experience in managing solid tumors and hematological malignancies. Additionally, he contributed his expertise at VPS Rockland Hospital in Qutub and Manesar, Paras Hospital, and C.K. Birla Hospital, further expanding his knowledge and skills. Dr. Mohit Saxena's comprehensive experience, combined with his expertise in various treatment modalities, enables him to provide optimal care to patients with different types of cancer. He believes in a multidisciplinary approach, working closely with a team of healthcare professionals to develop personalized treatment plans tailored to each patient's unique needs.

Education & Training

MBBS - University of Rajasthan, 2005; MD - General Medicine - Rajasthan University of Health Sciences, 2010; DM - Oncology - Gujarat University, India, 2016

Conditions Treated By Dr. Mohit Saxena

Treatment & Procedures Performed By Dr. Mohit Saxena

Awards & Achievements

Saxena M, Madabhavi I, Patel A et al. Treating low- and intermediate-risk acute promyelocytic leukaemia with and without chemotherapy: A comparison in a tertiary care centre. Journal of Cancer Research and Therapeutics. 2023 Apr; DOI: 10.4103/jcrt.jcrt_436_21; Saxena M, Madabhavi I, Patel A et al. Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. Int J Hematol Oncol Stem Cell Res 2018 Jul 1; 12(3): 197-203; Saxena M. Panchal H P. Parikh S K et al. High dose Cytarabinearabinoside (Ara-C) as a culprit of leukoencephalopathy in a patient of acute myeloid leukemia. Vidarbha Journal of Internal Medicine 2015 July: 19: 63-66.

Past Association

2016 - 2016 Senior Resident (Medical Oncology) at Gujarat Cancer & Research Institute; 2017 - 2018 Associate Consultant (Medical Oncology) at VPS Rockland Hospital; 2016 - 2019 Consultant (Medical Oncology) at Artemis Hospital; 2022 - 2023 Consultant (Medical Oncology) at C. K. Birla Hospital; 2019 - 2020 Consultant (Medical Oncology) at C. K. Birla Hospital; 2019 - 2019 Consultant (Medical Oncology) at Paras Hospital; 2019 - 2020 Empaneled Consultant (Medical Oncology) at Fortis Hospital
Get Assistance
error goes here
Get Free Assistance :